Skip to main content
. 2020 Oct 25;42(2):152–161. doi: 10.1093/eurheartj/ehaa736

Figure 2.

Figure 2

Finerenone reduces cofactor recruitment to the mineralocorticoid receptor, thereby reducing downstream expression of pro-inflammatory and pro-fibrotic factors following mineralocorticoid receptor overactivation. MR, mineralocorticoid receptor.